"Mice, Inbred BALB C" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research.
| Descriptor ID |
D008807
|
| MeSH Number(s) |
B01.050.050.199.520.520.338 B01.050.150.900.649.313.992.635.505.500.400.338
|
| Concept/Terms |
Mice, Inbred BALB C- Mice, Inbred BALB C
- BALB C Mouse, Inbred
- Inbred BALB C Mice
- Mouse, BALB C
- BALB C Mouse
- Mouse, Inbred BALB C
- Mice, BALB C
- BALB C Mice
- BALB C Mice, Inbred
- Inbred BALB C Mouse
|
Below are MeSH descriptors whose meaning is more general than "Mice, Inbred BALB C".
Below are MeSH descriptors whose meaning is more specific than "Mice, Inbred BALB C".
This graph shows the total number of publications written about "Mice, Inbred BALB C" by people in this website by year, and whether "Mice, Inbred BALB C" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 3 | 3 |
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 3 | 3 |
| 1998 | 0 | 1 | 1 |
| 1999 | 1 | 5 | 6 |
| 2000 | 0 | 3 | 3 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 8 | 8 |
| 2003 | 0 | 7 | 7 |
| 2004 | 0 | 6 | 6 |
| 2005 | 0 | 9 | 9 |
| 2006 | 0 | 8 | 8 |
| 2007 | 0 | 11 | 11 |
| 2008 | 0 | 6 | 6 |
| 2009 | 0 | 12 | 12 |
| 2010 | 0 | 8 | 8 |
| 2011 | 0 | 9 | 9 |
| 2012 | 0 | 11 | 11 |
| 2013 | 0 | 11 | 11 |
| 2014 | 0 | 13 | 13 |
| 2015 | 0 | 13 | 13 |
| 2016 | 0 | 7 | 7 |
| 2017 | 0 | 7 | 7 |
| 2018 | 0 | 7 | 7 |
| 2019 | 0 | 10 | 10 |
| 2020 | 0 | 7 | 7 |
| 2021 | 0 | 7 | 7 |
| 2022 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
| 2025 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mice, Inbred BALB C" by people in Profiles.
-
Exosome-Associated MTA1 in Circulation Is Elevated During Breast Cancer Progression. FASEB J. 2025 Jul 31; 39(14):e70872.
-
CHD4 drives gastric cancer metastasis via MYH9/GSK3?/?-catenin axis and WNT/EMT pathway activation. Cancer Lett. 2025 Sep 28; 628:217813.
-
Immunogenic Treatment of Metastatic Breast Cancer Using Targeted Carbon Nanotube Mediated Photothermal Therapy in Combination with Anti-Programmed Cell Death Protein-1. J Pharmacol Exp Ther. 2024 Jun 21; 390(1):65-77.
-
Peptide Aggregation Induced Immunogenic Rupture (PAIIR). Adv Sci (Weinh). 2022 07; 9(21):e2105868.
-
PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy. J Immunother Cancer. 2021 10; 9(10).
-
Passive Transfer of Blood Sera from ALS Patients with Identified Mutations Results in Elevated Motoneuronal Calcium Level and Loss of Motor Neurons in the Spinal Cord of Mice. Int J Mol Sci. 2021 Sep 16; 22(18).
-
Antifungal activity of dendritic cell lysosomal proteins against Cryptococcus neoformans. Sci Rep. 2021 06 30; 11(1):13619.
-
Early infiltrating macrophage subtype correlates with late-stage phenotypic outcome in a mouse model of hepatorenal fibrocystic disease. Lab Invest. 2021 10; 101(10):1382-1393.
-
Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1?. Proc Natl Acad Sci U S A. 2021 05 25; 118(21).
-
Borrelia peptidoglycan interacting Protein (BpiP) contributes to the fitness of Borrelia burgdorferi against host-derived factors and influences virulence in mouse models of Lyme disease. PLoS Pathog. 2021 04; 17(4):e1009535.